Wellgistics Health Taps Top Blockchain Platforms for Patent-Protected Drug Tracking System
Summary
Wellgistics Health, a health information technology leader, has announced the selection of five major blockchain platforms (Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum/Besu, and Corda (R3)) to initiate development of its patent-protected PharmacyChain™ system. This smart contracts-enabled platform aims to support industry-wide pharmaceutical drug serialization mandates, such as the DSCSA. The company plans to complete initial development for its own pharmacy by the end of Q2 2026, with broader rollout to its network of 6,500+ independent pharmacies later this year. This strategic move positions the micro-cap company in the rapidly growing blockchain in healthcare market, which is projected to reach $214 billion by 2030, and the substantial U.S. prescription drug market. While the immediate financial impact is not yet realized, this development signals a significant long-term growth opportunity and potential competitive advantage due to its intellectual property. Investors should monitor progress on the development timeline and any future partnerships or adoption by major industry players.
At the time of this announcement, WGRX was trading at $0.21 on NASDAQ in the Technology sector, with a market capitalization of approximately $19.1M. The 52-week trading range was $0.21 to $7.04. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Acceswire.